Loading clinical trials...
Loading clinical trials...
Clinical Trial, Randomized, Open Label, With an Active Comparator to Assess the Efficacy and Safety of Using Accelerated Partial Irradiation Versus Standard or Hypofractionated Irradiation of the Entire Breast in Patients With Initial Breast Cancer After Conservative Surgery
Radiotherapy has been confirmed as an important treatment breast-conserving surgery reducing the risk of any recurrence of breast cancer and breast cancer-related mortality in patients with early breast cancer. There are no comparative data on the ideal radiotherapy treatment regimen for patients with early stage breast cancer who underwent conservative surgery in the Brazilian population.
The investigators propose a prospective, randomized, pilot study, with active control, to evaluate the viability and safety of accelerated partial breast irradiation, in 5 fractions, comparing with the radiotherapy regimens of the whole breast in 15 and 5 fractions, in patients with breast cancer, in initial stage, who underwent conservative surgery.
Age
50 - 90 years
Sex
FEMALE
Healthy Volunteers
No
IBCC Oncologia
São Paulo, São Paulo, Brazil
Start Date
March 4, 2021
Primary Completion Date
December 7, 2025
Completion Date
December 31, 2026
Last Updated
March 8, 2021
36
ESTIMATED participants
Active Comparator: Standard
RADIATION
Experimental 1: Hypofractionated radiotherapy
RADIATION
Experimental 2: Accelerated Partial Breast Irradiation
RADIATION
Lead Sponsor
Instituto Brasileiro de Controle do Cancer
NCT07067138
NCT06878248
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions